Dr. Zafar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-648-8765Fax+1 214-645-8769
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Urologic Surgical Oncology, 2021 - 2023
Washington University/B-JH/SLCH ConsortiumResidency, Urology, 2016 - 2021
Baylor College of MedicineClass of 2016
Certifications & Licensure
TX State Medical License 2023 - 2025
MA State Medical License 2021 - 2024
MO State Medical License 2016 - 2021
Publications & Presentations
PubMed
- 8 citationsSequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy.Kendrick Yim, Kevin Melnick, Sarah L Mott, Filipe L F Carvalho, Affan Zafar
Urologic Oncology. 2023-11-01 - 14 citationsAssociation of BCG Vaccine Treatment With Death and Dementia in Patients With Non-Muscle-Invasive Bladder Cancer.Marc S Weinberg, Affan Zafar, Colin Magdamo, Sun Young Chung, Wesley H Chou
JAMA Network Open. 2023-05-01 - 6 citationsBreast Medical Oncologists' Perspectives of Telemedicine for Breast Cancer Care: A Survey Study.Eleni Stavrou, Jeanna Qiu, Affan Zafar, Angela C Tramontano, Steven Isakoff
JCO Oncology Practice. 2022-09-01
Press Mentions
Bladder Cancer Trimodal Therapy’s Effects on Long-Term Renal Function DescribedApril 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
